Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 6.

Rossi, Niccolo, Lee, Karla A, Bermudez, Maria V, Visconti, Alessia, Thomas, Andrew Maltez, Bolte, Laura A, Bjork, Johannes R, Ruijter, Laura Kist de, Newton-Bishop, Julia, Harland, Mark
et al (show 16 more authors) (2022) Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma. EBIOMEDICINE, 83. 104235-.

Carvajal, Richard D, Butler, Marcus O, Shoushtari, Alexander N, Hassel, Jessica C, Ikeguchi, Alexandra, Hernandez-Aya, Leonel, Nathan, Paul, Hamid, Omid, Piulats, Josep M, Rioth, Matthew
et al (show 11 more authors) (2022) Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature Medicine, 28 (11). 2364-+.

Nathan, Paul, Hassel, Jessica C, Rutkowski, Piotr, Baurain, Jean-Francois, Butler, Marcus O, Schlaak, Max, Sullivan, Ryan J, Ochsenreither, Sebastian, Dummer, Reinhard, Kirkwood, John M
et al (show 18 more authors) (2021) Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. NEW ENGLAND JOURNAL OF MEDICINE, 385 (13). pp. 1196-1206.

Carvajal, Richard D, Nathan, Paul, Sacco, Joseph J, Orloff, Marlana, Hernandez-Aya, Leonel F, Yang, Jessica, Luke, Jason J, Butler, Marcus O, Stanhope, Sarah, Collins, Laura
et al (show 4 more authors) (2022) Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of Clinical Oncology, 40 (17). 1939-+.

Cebon, Jonathan S, Gore, Martin, Thompson, John F, Davis, Ian D, McArthur, Grant A, Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P Rod, MacGregor, Duncan
et al (show 23 more authors) (2020) Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (1). e000410-.

Visconti, Alessia, Rossi, Niccolo, Deris, Helena, Lee, Karla A, Hanic, Maja, Trbojevic-Akmacic, Irena, Thomas, Andrew M, Bolte, Laura A, Bjork, Johannes R, Hooiveld-Noeken, Jahlisa S
et al (show 17 more authors) (2023) Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma. BMC CANCER, 23 (1). 166-.

This list was generated on Wed May 24 10:20:09 2023 BST.